Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: A randomized controlled study

International Journal of Dermatology

Volumn 51, Issue 9, 2012, Pages 1107-1115

  Sapam, Ranjeeta ^a   Agrawal, Sudha ^a   Dhali, Tapan K ^a  

^a B P KOIRALA INSTITUTE OF HEALTH SCIENCES   (Nepal)

Author keywords

[No Author keywords available]

Indexed keywords

PSORALEN;

ADOLESCENT; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BODY SURFACE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIZZINESS; ERYTHEMA; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NARROWBAND ULTRAVIOLET B RADIATION; OUTCOME ASSESSMENT; PHOTOTHERAPY; PHOTOTOXICITY; PIGMENTATION; PUVA; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; REPIGMENTATION; SKINFOLD; SYSTEMIC THERAPY; THERAPY EFFECT; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; ULTRAVIOLET RADIATION; VITILIGO;

ADOLESCENT; ADULT; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; MALE; PUVA THERAPY; SINGLE-BLIND METHOD; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; ULTRAVIOLET THERAPY; VITILIGO; YOUNG ADULT;

EID: 84865373519     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2011.05454.x     Document Type: Article

References (14)

1. Rebat M, Halder H, Young CM. New and emerging therapies for vitiligo. Clin Dermatol 2000; 18: 79-85.
2. Lerner AB. Vitiligo.J Invest Dermatol 1959; 32: 285-310.
3. Hartmann A, Lurz C, Henning H, et al. Narrow-band UVB 311nm vs broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo. Int J Dermatol 2005; 44: 736-742.
4. Westerhof W, Krobotova NL. Treatment of vitiligo with UV-B radiation VS topical psoralen plus UV-A. Arch Dermatol 1997; 133: 1525-1528.
5. Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 2001; 44: 999-1003.
6. Parsad D, Kanwar AJ, Kumar B. Psoralen-ultraviolet A vs. narrow band ultraviolet B phototherapy for the treatment of vitiligo. J Eur Acad Dermatol Venereol 2006; 20: 175-177.
7. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000; 42: 245-253.
8. Njoo MD, Spiels PT, Bos JD, Westerhof W. Non-surgical repigmentation therapies in vitiligo: a meta-analysis of literature. Arch Dermatol 1998; 134: 1532-1540.
9. Bhatnagar A, Kanwar AJ, Parsad D, De D. Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study. J Eur Acad Dermatol Venereol 2007; 21: 638-642.
10. Yones SS, Roy A, Palmer M, et al. Randomized double-blind trial of treatment of vitiligo. Efficacy of psoralen-UV-A therapy vs narrowband-UV-B therapy. Arch Dermatol 2007; 143: 578-584.
11. Mofty El, Zaher H, Esmat S, et al. PUVA and PUVB in vitiligo - are they equally effective?Photodermatol Photoimmunol Photomed 2001; 17: 159-163.
12. Fitzpatrick TB, Pathak MA. Historical aspect of methoxsalen and other furocoumarins. J Invest Dermatol 1959; 32: 229-231.
13. McGregor JM, Hawk JLM. Acute effects of ultraviolet radiation on the skin. In: Freedberg IM, Eisen AZ, Wolff K, eds. Dermatology in General Medicine, 5th edn. New York: McGraw-Hill, 1999: 1555-1561
14. De Berker DAR, Sakuntabhai A, Diffey BL, et al. Comparison of psoralen UVB and psoralen UVA photochemotherapy in the treatment of psoriasis. J Am Acad Dermatol 1997; 36: 577-581.